1 Product identity
Ingredient risk
1 ingredient to use with caution
Ginger 250 mg Extract 5% Gingerols
Brandherbscience→Botanical Other (e.g. tea bag) 9 ingredients 1 caution DSLD #7116Net contents: 60 Caplet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2012-03-23
2 Ingredients (9)
IngredientGroupSafety
GingerGinger —
Microcrystalline CelluloseCellulose—
Stearic AcidStearic Acid—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Ginger Root — Limited Evidence
⚠ GI: heartburn at high doses
⚠ Antiplatelet effect
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
GLA — Limited Evidence
⚠ May lower seizure threshold
⚠ Borage oil: hepatotoxic unless PA-free
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID7116
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2012-03-23
6 More from herbscience
View herbscience Safety Scorecard → 10 products
Aloe Vera 500 mg with YuccaBlack Cohosh 80 mg extractCranberry 500 mg with ChokeberryEchinacea 500 mgGarlic 600 mg Odorless extractMilk Thistle 550 mg7 Cite this page
Vancouver
Pkhakadze G. Ginger 250 mg Extract 5% Gingerols — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 18]. Available from: https://supplement.ge/products/dsld-7116/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG